| NDC Code | 59572-711-01 |
|---|
| Package Description | 1 VIAL, GLASS in 1 CARTON (59572-711-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS |
|---|
| Product NDC | 59572-711 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Reblozyl |
|---|
| Non-Proprietary Name | Luspatercept |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | SUBCUTANEOUS |
|---|
| Start Marketing Date | 20191108 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA761136 |
|---|
| Manufacturer | Celgene Corporation |
|---|
| Substance Name | LUSPATERCEPT |
|---|
| Strength | 25 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Erythroid Maturation Agent [EPC], Increased Erythroid Cell Production [PE] |
|---|